Back to Market返回行情

HOLX Hologic, Inc.

USHealthcare
$76.01+0.00%ClosedMarket Cap: $16.97B

As of 2026-04-07 16:00

Why HOLX matters now

Hologic, Inc. (HOLX) is a US stock in Healthcare. The latest InvestLog snapshot shows $76.01 with +0.00% on the session and $16.97B in market capitalization; recent performance reads 1-month +0.00% and YTD +2.04%.

The latest financial table shown here is Q1 2026, with revenue of $1.05B, net income of $179.1M, and EPS of $0.79. Investors can compare that operating picture with valuation signals such as P/E 31.20 and FCF yield 5.9%.

The latest indexable market news headline is "Blackstone, TPG seek over $4 billion for Hologic's surgical unit, FT says" from Reuters.

Additional event context on this page matters because analyst consensus is Hold with a median target of $78.50; recent insider activity includes COHN BENJAMIN JORDAN filing D-Return; recent congressional disclosure data includes Laura Friedman Exchange. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

31.20

PEG

P/B

3.25

P/S

4.11

EV/EBITDA

17.08

DCF Value

$108.60

FCF Yield

5.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

52.8%

Operating Margin

17.5%

Net Margin

13.2%

ROE

11.0%

ROA

5.9%

ROIC

7.2%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$1.05B$179.1M$0.79
Q4 2025$1.05B$187.3M$0.83
FY 2025$4.10B$565.7M$2.49
Q3 2025$1.02B$194.9M$0.86

Analyst Ratings

Consensus

Hold

Target (Consensus)

$78.69

Target (Median)

$78.50

Target Range

$33.00 - $95.00

Strong Buy: 0Buy: 0Hold: 15Sell: 0Strong Sell: 0
Argus ResearchHold
2026-01-12
Evercore ISI GroupIn Line
2026-01-05
Morgan StanleyEqual Weight
2025-11-11
MizuhoNeutral
2025-10-23
JP MorganNeutral
2025-10-22

Trading Activity

Insider Trades

COHN BENJAMIN JORDANofficer: Principal Accounting Officer
Sell2026-04-09
COHN BENJAMIN JORDANofficer: Principal Accounting Officer
Sell2026-04-09
COHN BENJAMIN JORDANofficer: Principal Accounting Officer
Sell2026-04-09
COHN BENJAMIN JORDANofficer: Principal Accounting Officer
Sell2026-04-09
COHN BENJAMIN JORDANofficer: Principal Accounting Officer
Sell2026-04-09

Congress Trades

Laura FriedmanSell
2026-05-15
Laura FriedmanSell
2026-05-15

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

US

Exchange

Beta

0.70

Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.